Cannabis use during the early COVID-19 pandemic: Use patterns, predictors, and subjective experiences.
COVID-19
SARS-CoV-2
THC
cannabis
pandemic
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
09
2022
accepted:
13
12
2022
entrez:
27
1
2023
pubmed:
28
1
2023
medline:
28
1
2023
Statut:
epublish
Résumé
Even in the early stages, global crises such as the COVID-19 pandemic lead to serious dislocations of social life, secondary adjustment reactions to external restrictions and individual concerns. Coping mechanisms may also include dysfunctional strategies like an increase of drug use. Considering the wide-spread use of cannabis, the aim of this study was to elucidate the interplay of social restrictions, psychopathology, concerns related to the pandemic in addition to the users' experiences, motivations and consumption quantities during the early COVID-19 pandemic. It was presumed that cannabis intake would increase during the early phase of the crisis and that consumption quantities would be related to corona-related restrictions, concerns as well as subjective substance effects and psychopathology. As part of an international, cross-sectional, internet-based survey ( Cannabis use behavior showed no significant differences when consumption quantities prior and during 1 month after the COVID-19 outbreak were compared. Higher quantities of cannabis intake prior and during 1 month of the pandemic as well as more corona-related concern were associated with an increased perception of positive effects of cannabis during the pandemic. Predictors of its use during 1 month of pandemic were higher pre-pandemic consumption quantity, older age, quarantinization, a lesser degree of being affected by negative effects of the pandemic and a stronger subjective experience of corona-related positive effects of cannabis. Comparisons of the motives for cannabis intake in the pre-pandemic versus the pandemic period showed that all rationales for consumption were reported less frequently, except boredom. Frequencies of cannabis intake remained relatively stable in the early pandemic phase. Risk factors for increased use seem related to habitual consumption patterns that become more prominent under quarantinization. The use of cannabis as a dysfunctional coping strategy might not be amenable
Sections du résumé
Background
UNASSIGNED
Even in the early stages, global crises such as the COVID-19 pandemic lead to serious dislocations of social life, secondary adjustment reactions to external restrictions and individual concerns. Coping mechanisms may also include dysfunctional strategies like an increase of drug use. Considering the wide-spread use of cannabis, the aim of this study was to elucidate the interplay of social restrictions, psychopathology, concerns related to the pandemic in addition to the users' experiences, motivations and consumption quantities during the early COVID-19 pandemic. It was presumed that cannabis intake would increase during the early phase of the crisis and that consumption quantities would be related to corona-related restrictions, concerns as well as subjective substance effects and psychopathology.
Materials and methods
UNASSIGNED
As part of an international, cross-sectional, internet-based survey (
Results
UNASSIGNED
Cannabis use behavior showed no significant differences when consumption quantities prior and during 1 month after the COVID-19 outbreak were compared. Higher quantities of cannabis intake prior and during 1 month of the pandemic as well as more corona-related concern were associated with an increased perception of positive effects of cannabis during the pandemic. Predictors of its use during 1 month of pandemic were higher pre-pandemic consumption quantity, older age, quarantinization, a lesser degree of being affected by negative effects of the pandemic and a stronger subjective experience of corona-related positive effects of cannabis. Comparisons of the motives for cannabis intake in the pre-pandemic versus the pandemic period showed that all rationales for consumption were reported less frequently, except boredom.
Conclusion
UNASSIGNED
Frequencies of cannabis intake remained relatively stable in the early pandemic phase. Risk factors for increased use seem related to habitual consumption patterns that become more prominent under quarantinization. The use of cannabis as a dysfunctional coping strategy might not be amenable
Identifiants
pubmed: 36704748
doi: 10.3389/fpsyt.2022.1037451
pmc: PMC9872100
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1037451Informations de copyright
Copyright © 2023 Mielau, Reiche, Moon, Groß, Gutwinski, Betzler, Romanello, Jalilzadeh Masah, Scicchitano, Marek, Brandt, Evens, Mick, Majić and Montag.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Drug Policy. 2021 Jun;92:103053
pubmed: 33250438
Psychiatry Res. 2020 Sep;291:113264
pubmed: 32622172
Adicciones. 2021 Jan 15;33(1):31-42
pubmed: 31018002
Int J Environ Res Public Health. 2021 Oct 28;18(21):
pubmed: 34769848
Eur Addict Res. 2020;26(6):309-315
pubmed: 32961535
Subst Abus. 2020;41(4):409-412
pubmed: 33044893
Addiction. 2021 Aug;116(8):2104-2115
pubmed: 33394560
BMC Psychiatry. 2013 Mar 28;13:104
pubmed: 23537095
Addiction. 2021 Dec;116(12):3369-3380
pubmed: 34109685
Addict Behav. 2015 Jan;40:91-5
pubmed: 25240105
Addiction. 2021 Jun;116(6):1381-1388
pubmed: 33006789
Front Psychiatry. 2021 Oct 12;12:748158
pubmed: 34712158
Psychiatry Res. 2020 Nov;293:113407
pubmed: 32827993
Aust N Z J Psychiatry. 2008 Dec;42(12):1060-5
pubmed: 19016094
Drug Alcohol Depend. 2017 Sep 1;178:136-142
pubmed: 28647681
Am J Drug Alcohol Abuse. 2022 Jan 2;48(1):88-99
pubmed: 35007453
Lancet. 2007 Jul 28;370(9584):319-28
pubmed: 17662880
J Psychiatr Res. 2021 Jul;139:47-53
pubmed: 34029833
Int J Emerg Ment Health. 2009 Summer;11(3):137-44
pubmed: 20437844
Arch Gen Psychiatry. 1994 Apr;51(4):273-9
pubmed: 8161287
Front Psychol. 2020 Sep 16;11:567784
pubmed: 33041933
Eur Psychiatry. 2005 Jun;20(4):349-53
pubmed: 16018929
J Stud Alcohol Drugs. 2021 Mar;82(2):228-236
pubmed: 33823970
Int J Drug Policy. 2022 Apr;102:103582
pubmed: 35093679
BMC Med. 2020 Jul 31;18(1):241
pubmed: 32731868
Schizophr Bull. 2011 May;37(3):631-9
pubmed: 19915168
Front Psychiatry. 2020 Dec 21;11:601653
pubmed: 33408655
Br J Psychiatry. 2008 Nov;193(5):357-63
pubmed: 18978312
Asian J Psychiatr. 2020 Jun;51:102086
pubmed: 32315968
Rev Panam Salud Publica. 2021 May 20;45:e52
pubmed: 34025727
Front Psychiatry. 2021 Nov 11;12:689634
pubmed: 34858218
Front Psychiatry. 2021 Nov 04;12:732028
pubmed: 34803757
J Addict Dis. 2021 Oct-Dec;39(4):436-440
pubmed: 33595413
J Addict Dis. 2021 Jan-Mar;39(1):26-36
pubmed: 32933383
Psychiatry Investig. 2020 Jun;17(6):491-505
pubmed: 32570296